DWS
ABUS icon

Dynamic Wealth Strategies’s Arbutus Biopharma ABUS Stock Holding History

Dynamic Wealth Strategies’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,300
Closed -$22K – 235
2025
Q1 		$22K Buy
+6,300
New +$21K 0.02% 171
2024
Q4 		– Sell
-6,300
Closed -$24K – 67
2024
Q3 		$24K Hold
6,300
– – 0.02% 169
2024
Q2 		$19K Hold
6,300
– – 0.02% 161
2024
Q1 		$16K Hold
6,300
– – 0.01% 173
2023
Q4 		$15.8K Buy
+6,300
New +$12.3K 0.01% 183

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BCP
BlackBarn Capital Partners New York $1.24B AUM 55.98% 1-Year Est. Return

Dynamic Wealth Strategies's ABUS Position: Q2 2025 in Review

Dynamic Wealth Strategies sold out of Arbutus Biopharma (ABUS) in Q2 2025, closing a stake of 6,300 shares — an estimated $22K sold.

Dynamic Wealth Strategies first reported a position in ABUS in Q4 2023 and held it in 5 quarters. The position peaked at $24K in Q3 2024. 162 funds tracked by Wall St. Rank hold ABUS as of Q2 2025.

  • Dynamic Wealth Strategies reported no remaining Arbutus Biopharma position as of Q2 2025 after selling out during the quarter.
  • Dynamic Wealth Strategies sold 6,300 Arbutus Biopharma shares in Q2 2025, an estimated $22K.
  • Dynamic Wealth Strategies first reported a position in Arbutus Biopharma in Q4 2023 and held it in 5 quarters.
  • Dynamic Wealth Strategies's Arbutus Biopharma position peaked at $24K in Q3 2024.
  • 162 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2025.

Based on Dynamic Wealth Strategies's 13F filing for Q2 2025, filed 13 Aug 2025.